University of Harvard’s Wyss Institute

article

The diversity of synthetic biology applications

23 September 2021 | By Dr Jim Collins (MIT)

Synthetic biology processes can be useful to therapeutic development, diagnostics and vaccine advancement. Drug Target Review’s Victoria Rees spoke with Dr Jim Collins, Termeer Professor of Medical Engineering & Science at MIT and Founding Core Faculty & Lead, Living Cellular Devices at the Wyss Institute at Harvard University, to explore…

article

Body-on-chip technology: resolving current limitations in drug discovery

30 January 2020 | By Victoria Rees (Drug Target Review)

Researchers have developed a new body-on-chip technology that can demonstrate the pharmacokinetics and pharmacodynamics of drugs in a pre-clinical setting without the need for animal testing.